Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and Health Care Groups have...more
3/13/2025
/ Enforcement Actions ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Life Sciences ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Requirements ,
Supply Chain ,
Telehealth ,
Telemedicine
Loosening regulations on telehealth during the coronavirus pandemic has, unsurprisingly, led to a boom in telehealth use. At the same time, telehealth has emerged as a key enforcement initiative of the Department of Justice...more
Federal agencies have relaxed telehealth regulations to improve and expedite patient care during the coronavirus (COVID-19) pandemic. Our Health Care and Health Care Litigation Groups explore how to take advantage of remote...more
Regulations are falling behind the technological wave sweeping health care, and the Congressional Telehealth Caucus is taking note and asking for comments. Our Health Care Group considers a few ideas to remove legal obstacles...more